Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism / Q000633:toxicity; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy; D007274:Injections, Intraperitoneal; D007700:Kinetics; D010529:Peritoneal Cavity / Q000378:metabolism; D010534:Peritoneal Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents